Pure Global

18F-LN1 PET/CT in Urothelial Carcinomas - Trial NCT06120413

Access comprehensive clinical trial information for NCT06120413 through Pure Global AI's free database. This phase not specified trial is sponsored by Sichuan Provincial People's Hospital and is currently Recruiting. The study focuses on Urothelial Carcinoma. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06120413
Recruiting
Trial Details
ClinicalTrials.gov โ€ข NCT06120413
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
18F-LN1 PET/CT in Urothelial Carcinomas
Clinical Evaluation of 18F-LN1 PET/CT for Imaging of Nectin-4 in Urothelial Carcinomas

Study Focus

Urothelial Carcinoma

Observational

Sponsor & Location

Sichuan Provincial People's Hospital

Chengdu, China

Timeline & Enrollment

N/A

Nov 01, 2023

Oct 01, 2024

30 participants

Primary Outcome

Comparison of 18F-LN1 and 18F-FDG Uptake in Patients with urothelial carcinoma

Summary

The clinical feasibility of 18F-LN1 PET/CT will be evaluated in 30 patients with urothelial
 carcinoma, and the results will be compared with those of 18F-FDG.

ICD-10 Classifications

Carcinoma in situ: Other and unspecified urinary organs
Malignant neoplasm of ureter
Malignant neoplasms of urinary tract
Malignant neoplasm: Overlapping lesion of urinary organs
Malignant neoplasm: Urethra

Data Source

ClinicalTrials.gov

NCT06120413

Non-Device Trial